Entrada Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Mar 24 | BuyUS$122,882 | Peter Kim | Individual | 9,048 | US$13.76 | |
21 Mar 24 | BuyUS$34,996 | Peter Kim | Individual | 2,732 | US$13.24 |
Insider Trading Volume
Insider Buying: TRDA insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,780 | 0.0179% |
Individual Insiders | 560,275 | 1.73% |
General Public | 903,727 | 2.8% |
Public Companies | 2,744,120 | 8.49% |
Hedge Funds | 4,865,819 | 15% |
VC/PE Firms | 10,573,931 | 32.7% |
Institutions | 12,678,990 | 39.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,865,819 | US$69.8m | 0% | 0.79% | |||
4,425,784 | US$63.5m | 0% | 21.98% | |||
4,408,379 | US$63.3m | 0% | 10.84% | |||
3,009,673 | US$43.2m | 0.32% | no data | |||
2,744,120 | US$39.4m | -2.47% | no data | |||
1,739,768 | US$25.0m | 0% | 95.79% | |||
1,502,537 | US$21.6m | 6.99% | no data | |||
1,283,735 | US$18.4m | -0.02% | 0.64% | |||
1,065,166 | US$15.3m | 4.4% | no data | |||
1,047,780 | US$15.0m | 0.2% | no data | |||
761,277 | US$10.9m | 0% | 2.21% | |||
584,955 | US$8.4m | 0% | 0.66% | |||
535,523 | US$7.7m | -8% | no data | |||
459,381 | US$6.6m | 4.74% | no data | |||
427,832 | US$6.1m | 6.1% | no data | |||
238,645 | US$3.4m | 71.9% | no data | |||
200,688 | US$2.9m | -2.13% | no data | |||
172,600 | US$2.5m | -66.1% | no data | |||
151,358 | US$2.2m | -2.49% | no data | |||
137,204 | US$2.0m | 1,830% | no data | |||
129,942 | US$1.9m | 3.32% | no data | |||
122,319 | US$1.8m | 9.26% | no data | |||
119,254 | US$1.7m | 0% | no data | |||
115,060 | US$1.7m | 71.8% | no data | |||
105,137 | US$1.5m | 0% | 0.26% |